MGC Pharmaceuticals: Developing a COVID treatment
Listen to ASX-listed MGC Pharmaceuticals VP of International Relations Ron Lipsky talk to Matt Birney on the Bulls N’ Bears Report about the latest developments in MGC’s quest to develop a treatment for COVID-19.